DOI: https://doi.org/10.22141/2224-0721.0.4.44.2012.177302

Diabetes Mellitus: New Views and Old Delusions. Part 2. Pevention of Diabetes Mellitus Type 2

A.V. Kaminsky

Abstract


No abstract


References


Schwarz P.E., Gruhl U., Bornstein S. et al. The European perspective on diabetes prevention: development and Implementation of A European Guideline and training standards for diabetes prevention (IMAGE) // Diab. Vasc. Dis. Res. — 2007. — № 4. — Р. 353-357.

Pajunen P., Landgraf R., Muylle F. et al. for the IMAGE Study Group. Quality indicators for the prevention of type 2 diabetes in Europe — IMAGE // Horm. Metab. Res. — 2010. — Vol. 42 (suppl. 1). — P. 56-63.

Schwarz P., Reddy P., Greaves C. et al. Diabetes Prevention in Practice. — Dresden: Tuamini Institute for Prevention Management. — 2010. — P. 88-91.

The Diabetes Prevention Program Research Group. Role of Insulin Secretion and Sensitivity in the Evolution of Type 2 Diabetes in the Diabetes Prevention Program Effects of Lifestyle Intervention and Metformin // Diabetes. — 2005. — Vol. 54, № 8. — Р. 2404-2414.

International Diabetes Federation. Global IDF/ISPAD guideline for diabetes in childhood and adolescence. — Brussels: IDF, 2011. — 130 р.

Tuomilehto J., Lindstrom J., Eriksson J.G. et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance // N. Engl. J. Med. — 2001. — Vol. 344. — P. 1343-1350.

Lindstrom J., Ilanne-Parikka P., Peltonen M. et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study // Lancet. — 2006. — Vol. 368. — P. 1673-1679.

Knowler W.C., Barrett-Connor E., Fowler S.E. et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin // N. Engl. J. Med. — 2002. — Vol. 346. — P. 393-403.

World Health Organization. Fact sheet № 312 (August 2011) // http://www.who.int/mediacentre/factsheets/fs312/en.

Standards of Medical Care in Diabetes — 2011 // Diabetes Care. — 2011. — Vol. 34 (suppl. 1). — P. 11-61.

Standards of Medical Care in Diabetes — 2012 // Diabetes Care. — 2012. — Vol. 35 (suppl. 1). — Р. 11-63.

Diabetes Prevention Program Research Group (Bray G.A., Edelstein S.L., Crandall J.P. et al.). Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study // Diabetes Care. — 2012. — Vol. 35, № 4. — Р. 731-737.

The Diabetes Prevention Program Research Group. The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention An intent-to-treat analysis of the DPP/

DPPOS // Diabetes Care. — 2012. — Vol. 35, № 4. — Р. 723-730.

Currie C.J. et al. Mortality After Incident Cancer in People With and Without Type 2 Diabetes Impact of metformin on survival // Diabetes Care. — 2012. — Vol. 35, № 2. — Р. 299-304.

Nathan D.M., Buse J.B., Davidson M.B. et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes // Diabetes Care. — 2009. — Vol. 32. — P. 193-203.

Rodbard H.W. Diabetes screening, diagnosis, and therapy in pediatric patients with type 2 diabetes [online exclusive article] // Medscape J. Med. — 2008. — № 10. — Р. 184. (Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2562149).

Cefalu W.T. Steps Toward the Meaningful Translation of Prevention Strategies for Type 2 Diabetes // Diabetes Care. — 2012. — Vol. 35. — P. 663-665.






Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2019

 

   Seo анализ сайта